Phase I pharmacokinetic and safety trial of reformulated Z 160.

Trial Profile

Phase I pharmacokinetic and safety trial of reformulated Z 160.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2012

At a glance

  • Drugs Z 160 (Primary)
  • Indications Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 May 2012 This trial evaluated a number of formulations of Z 160, and the optimal formulation has been selected for further clinical studies, according to a Zalicus media release.
    • 05 Mar 2012 Status changed from recruiting to completed, according to a Zalicus media release.
    • 05 Dec 2011 Status changed from planning to recruiting, according to a Zalicus media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top